HTG MOLECULAR DIAGNOSTICS (HTGM) Earnings History & Surprises

NASDAQ:HTGM • US40434H3021

Current stock price

0.48 USD
-0.12 (-20%)
At close:
0.4815 USD
+0 (+0.31%)
After Hours:

HTGM Earnings overview

Past quarterly earnings results for HTG MOLECULAR DIAGNOSTICS (HTGM), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Aug 9, 2023
Period
Q2 / 2023
EPS Estimate
-$1.88
Revenue Estimate
1.632M

Last Reported

Most Recent
Release Date
May 10, 2023
Period
Q1 / 2023
EPS Reported
-$2.28
EPS Surprise
-15.22%
Revenue Surprise
-36.73%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q1 2023 -2.28 -1.98 -15.22% 76.54% 1.033M 1.632M -36.73% -12.83%
Q4 2022 -4.47 -2.46 -81.95% 45.98% 2.439M 2.484M -1.80% -15.22%
Q3 2022 -4.92 -6.55 24.87% 31.67% 1.251M 2.907M -56.97% -50.37%
Q2 2022 -6.48 -7.41 12.49% 16.92% 1.492M 2.55M -41.51% -28.09%
Q1 2022 -9.72 -8.75 -11.07% -1.25% 1.184M 2.193M -45.99% -17.75%
Q4 2021 -8.28 -7.18 -15.31% 25.81% 2.877M 3.026M -4.92% 11.51%
Q3 2021 -7.20 -8.14 11.54% 42.86% 2.52M 2.703M -6.76% 41.60%
Q2 2021 -7.80 -9.39 16.97% 45.83% 2.074M 2.168M -4.33% 5.83%
Q1 2021 -9.60 -12.48 23.11% 33.33% 1.44M 1.729M -16.71% -35.43%
Q4 2020 -11.16 -13.77 18.95% - 2.58M 2.372M 8.77% -
Q3 2020 -12.60 -14.23 11.45% - 1.78M 2.273M -21.69% -
Q2 2020 -14.40 -15.61 7.73% - 1.96M 1.823M 7.52% -
Q1 2020 -14.40 -16.07 10.36% - 2.23M 2.871M -22.33% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

HTGM EPS Q2Q GrowthHTGM EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 0 20 40 60 80

Revenue Historical Q2Q growth and Acceleration

HTGM Revenue Q2Q GrowthHTGM Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 0 20 -20 40 -40

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
2
Average EPS beat (4)
-14.95%
Max EPS beat (4)
24.87%
Min EPS beat (4)
-81.95%

Revenue beat statistics

Revenue beat (4)
0
Average Revenue beat (4)
-34.25%
Max Revenue beat (4)
-1.80%
Min Revenue beat (4)
-56.97%

Analysis

In the last 4 quarters, HTGM has beaten EPS estimates in 2 out of 4 releases
HTGM has not beaten revenue estimates in any of the last 4 earnings releases
In the last 4 quarters, HTGM reported -15.0% below the EPS estimates on average.
In the last 4 quarters, HTGM reported -34.3% below the revenue estimates on average.
HTGM Overview HTGM Technical Analysis Report HTGM Fundamental Analysis Report HTGM Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

HTG MOLECULAR DIAGNOSTICS / HTGM Earnings FAQ

When did HTG MOLECULAR DIAGNOSTICS (HTGM) report earnings last quarter?

HTG MOLECULAR DIAGNOSTICS (HTGM) last reported earnings on 5/10/2023.

Did HTGM stock beat earnings estimates in the most recent quarter?

HTG MOLECULAR DIAGNOSTICS (HTGM) missed EPS estimates and missed revenue estimates in the most recent quarter.

Can you provide information on how often HTG MOLECULAR DIAGNOSTICS beats earnings estimates?

In the last 4 quarters, HTG MOLECULAR DIAGNOSTICS (HTGM) has beaten EPS estimates in 2 out of 4 releases.